Hot topics | Coronavirus pandemic

Remedium Bio announced a research agreement with the leading Rheumatology laboratory

Remedium Bio announced a research agreement with the leading Rheumatology laboratory

Remedium Bio, Inc., a biotechnology company that developed novel gene therapies, is proud to announce it has entered into if approved partnering with Tufts University's foremost Rheumatology lab to develop The research is being led by Dr. Li Zeng, PhD, the Associate Professor of Immunology at Tufts University School of Medicine, whose laboratory has developed in vitro, ex vivo and in obstruct Dr. Zeng is well-known for her extensive experience in preclinical Rheumatology. Her laboratory has produced high-impact publications in journals such as Nature Scientific Reports, Nature Laboratory Investigations and Development, Journal of Clinical Investigation, and Osteoarthritis & Cartilage.

You may also like: